Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China
· Delayed Price · Currency is CNY 54.16
+2.66 (5.17%)
Mar 10, 2026, 3:00 PM CST
SHA:688091 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | - | 649.53 | 914.76 | 710.38 | 110.43 | Upgrade
|
| Short-Term Investments | - | 21.7 | - | 78.46 | 10.05 | Upgrade
|
| Trading Asset Securities | - | - | 325.42 | 338.9 | 832.65 | Upgrade
|
| Cash & Short-Term Investments | 485.4 | 671.23 | 1,240 | 1,128 | 953.13 | Upgrade
|
| Cash Growth | -27.68% | -45.88% | 9.97% | 18.32% | 1774.41% | Upgrade
|
| Accounts Receivable | - | 49.27 | 143.15 | 42.44 | 4.1 | Upgrade
|
| Other Receivables | - | 0.08 | - | - | 9.35 | Upgrade
|
| Receivables | - | 49.35 | 143.15 | 42.44 | 13.46 | Upgrade
|
| Inventory | - | 45.17 | 28.41 | 17.06 | 11.78 | Upgrade
|
| Prepaid Expenses | - | 2.71 | 0.53 | 1.76 | 3.36 | Upgrade
|
| Other Current Assets | - | 7.75 | 0.98 | 10.71 | 11.82 | Upgrade
|
| Total Current Assets | - | 776.21 | 1,413 | 1,200 | 993.55 | Upgrade
|
| Property, Plant & Equipment | - | 149.28 | 120.21 | 121.45 | 83.95 | Upgrade
|
| Long-Term Investments | - | 467.77 | 21.01 | 20.32 | 105.82 | Upgrade
|
| Other Intangible Assets | - | 8.36 | 8.58 | 8.79 | 9.01 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 7.62 | 5.65 | 1.84 | 6.07 | Upgrade
|
| Long-Term Deferred Charges | - | 8.59 | 1.86 | 0.22 | - | Upgrade
|
| Other Long-Term Assets | - | 30.16 | 2.81 | 2.25 | 2.16 | Upgrade
|
| Total Assets | - | 1,448 | 1,573 | 1,355 | 1,201 | Upgrade
|
| Accounts Payable | - | 24.7 | 31.83 | 13.58 | 0.74 | Upgrade
|
| Accrued Expenses | - | 5.52 | 7.56 | 6.08 | 1.62 | Upgrade
|
| Short-Term Debt | - | - | 44.03 | - | 16.75 | Upgrade
|
| Current Income Taxes Payable | - | - | 10.3 | - | - | Upgrade
|
| Current Unearned Revenue | - | 4.38 | 1.11 | 0.12 | - | Upgrade
|
| Other Current Liabilities | - | 4.84 | 9.16 | 10.08 | 2 | Upgrade
|
| Total Current Liabilities | - | 39.45 | 103.98 | 29.86 | 21.1 | Upgrade
|
| Long-Term Unearned Revenue | - | 1.03 | 1.47 | 2.29 | 3.13 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 2.5 | 3.07 | 3.26 | 0.79 | Upgrade
|
| Total Liabilities | - | 42.97 | 108.52 | 35.42 | 25.02 | Upgrade
|
| Common Stock | - | 206.59 | 158.28 | 143.89 | 105.8 | Upgrade
|
| Additional Paid-In Capital | - | 1,043 | 1,072 | 1,059 | 1,096 | Upgrade
|
| Retained Earnings | - | 192.59 | 234.68 | 116.29 | -26.56 | Upgrade
|
| Treasury Stock | - | -37.24 | - | - | - | Upgrade
|
| Shareholders' Equity | 1,461 | 1,405 | 1,465 | 1,319 | 1,176 | Upgrade
|
| Total Liabilities & Equity | - | 1,448 | 1,573 | 1,355 | 1,201 | Upgrade
|
| Total Debt | - | - | 44.03 | - | 16.75 | Upgrade
|
| Net Cash (Debt) | 485.4 | 671.23 | 1,196 | 1,128 | 936.38 | Upgrade
|
| Net Cash Growth | -27.68% | -43.88% | 6.07% | 20.44% | 1867.20% | Upgrade
|
| Net Cash Per Share | 2.35 | 2.89 | 7.55 | 5.47 | 6.02 | Upgrade
|
| Filing Date Shares Outstanding | 219.6 | 205.31 | 205.76 | 205.76 | 205.76 | Upgrade
|
| Total Common Shares Outstanding | 205.43 | 205.31 | 205.76 | 205.76 | 205.76 | Upgrade
|
| Working Capital | - | 736.76 | 1,309 | 1,170 | 972.45 | Upgrade
|
| Book Value Per Share | 7.11 | 6.84 | 7.12 | 6.41 | 5.71 | Upgrade
|
| Tangible Book Value | 1,432 | 1,397 | 1,456 | 1,310 | 1,167 | Upgrade
|
| Tangible Book Value Per Share | 6.97 | 6.80 | 7.08 | 6.37 | 5.67 | Upgrade
|
| Buildings | - | 80.55 | 80.55 | 80.55 | 80.55 | Upgrade
|
| Machinery | - | 81.55 | 76.29 | 35.23 | 29.38 | Upgrade
|
| Construction In Progress | - | 39.49 | 4.81 | 39.44 | 1.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.